Chelsea’s high‑profile winger Mykhailo Mudryk has taken his case to the Court of Arbitration for Sport (CAS) after the English Football Association imposed a four‑year ban for a doping violation. The CAS docket shows that Mudryk lodged his formal appeal on February 25, and the arbitration panel has acknowledged receipt of the request.
Neither the FA, Chelsea FC nor Mudryk’s legal team have offered public comments on the matter so far. Mudryk arrived at Stamford Bridge in January 2023 after Chelsea paid a reported £88 million to Shakhtar Donetsk for the 23‑year‑old Ukrainian international. His contract runs for another five years, meaning the potential loss of his services could have significant financial and sporting repercussions for the club.
The doping allegation stems from a positive test for the prohibited substance meldonium, a drug that is banned in sport because it can enhance endurance. Mudryk maintains that the sample was contaminated during his duties with the Ukraine national team in October 2024, and that he never knowingly ingested any banned material. The timeline of events began in December 2024, when the FA provisionally suspended Mudryk after the laboratory result returned a positive finding. In a statement released later that month, Mudryk described the outcome as "a complete shock" and insisted that he had "not done anything wrong." He emphasized that he had always complied with anti‑doping regulations and that the test result was inexplicable.
Chelsea launched its own internal investigation shortly after the FA’s provisional suspension. The club’s statement highlighted that Mudryk, then 23, had repeatedly affirmed that he had never deliberately taken any prohibited substances. The Blues also noted that they would cooperate fully with any external inquiries while continuing to support the player’s right to a fair process.
Since the initial suspension, Mudryk has been unable to feature for Chelsea. His last appearance for the club came on 28 November 2024, when he scored in a 2‑0 Conference League victory over German side Heidenheim. That match marked the end of an 18‑month period during which he has been sidelined, training independently with personal coaches away from the Cobham training ground.
Despite the lengthy absence, Mudryk has continued to keep fit, hoping to return to top‑level football should his appeal be successful. Sky Sports’ chief correspondent Kaveh Solhekol explained the limited information flow surrounding the case: "The only reason we know Mudryk has been banned by the Football Association is because it’s been confirmed by CAS that he has appealed against it to them. The FA themselves have said absolutely nothing, because this is a confidential process.
Chelsea have said nothing, and the player's lawyers are saying nothing either." Solhekol added context about Mudryk’s status at Chelsea, noting that the player was a marquee signing who has not played for the club in nearly a year and a half. "He gave a doping sample while he was on international duty with Ukraine, not when he was playing for them. That tested positive, and we believe it was for meldonium. He was provisionally suspended by the Football Association in December 2024, and we found out last June he was charged with an anti‑doping violation by them.
Since then, there has been radio silence. We've not known what's been going on – until today." The potential consequences of a failed appeal are severe. A four‑year ban, combined with the 18 months already served under provisional suspension, would keep Mudryk out of competitive football until the end of 2028.
Such a lengthy exclusion would represent a major setback for both the player’s career trajectory and Chelsea’s long‑term planning, given the substantial investment the club made in acquiring him. Legal experts note that doping cases often hinge on the chain of custody for the sample, the testing methodology, and any evidence of contamination. Mudryk’s legal team is expected to argue that the sample was compromised during travel or handling on international duty, a claim that, if substantiated, could lead to a reduction or overturning of the sanction. The CAS will review all documentation, including laboratory reports, witness statements, and any relevant medical records, before issuing a final ruling.
While the arbitration process unfolds, the football community continues to watch closely. The case raises broader questions about anti‑doping protocols for players who frequently move between club and national team commitments, and whether existing safeguards are sufficient to protect athletes from inadvertent contamination. Regardless of the outcome, Mudryk’s appeal underscores the high stakes involved when elite athletes face doping allegations. It also highlights the importance of transparent, timely communication from governing bodies, clubs, and player representatives to ensure that due process is respected and that the integrity of the sport is maintained.
As the CAS deliberations proceed, fans and analysts alike will be waiting for a definitive verdict that could either restore Mudryk’s career or cement a lengthy hiatus from the game. The next few months will be crucial in determining whether the Ukrainian winger can return to the Premier League stage or whether his time at Stamford Bridge will remain a costly chapter in Chelsea’s recent history.